glp 1 ocd Exploring glucagon-like peptide-1 receptor agonists as potential disease-modifying agent in psychiatric and neurodevelopmental conditions: evidence from a drug target Mendelian randomization | BMC Psychiatry GLP-1 receptor agonists in mental
Description
This content is not medical advice
Interested in learning more about GLP-1based weight management options
Methodology This narrative review was conducted using structured and transparent methods adapted from the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, while recognizing that a narrative review does not strictly follow systematic review methodology [10]
Notwithstanding these developments, only about 20% of patients with T1D achieve adequate glycemic control based on current targets (1)
Diabetic complications: an update on pathobiology and therapeutic strategies
Effect of nortriptyline on symptoms of idiopathic gastroparesis: The NORIG randomized clinical trial
